Carregant...
When should genetic testing be performed in patients with neuroendocrine tumours?
Neuroendocrine tumours (NETs) are a heterogenous group of tumours arising from neuroendocrine cells in several sites around the body. They include tumours of the gastroenteropancreatic system, phaeochromocytoma and paraganglioma and medullary thyroid cancer. In recent years, it has become increasing...
Guardat en:
| Publicat a: | Rev Endocr Metab Disord |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Springer US
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5849652/ https://ncbi.nlm.nih.gov/pubmed/28965289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11154-017-9430-3 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|